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MaBACKGROUND Inherited arrhythmias were originally considered isolated electrical defects. There is growing evidence
that ion channel dysfunction also contributes to myocardial disorders, but genetic overlap has not been reported for sinus
node dysfunction (SND) and noncompaction cardiomyopathy (NCCM).
OBJECTIVES The study sought to investigate a familial electromechanical disorder characterized by SND and NCCM,
and to identify the underlying genetic basis.
METHODS The index family and a cohort of unrelated probands with sinus bradycardia were examined by electrocar-
diography, Holter recording, exercise stress test, echocardiography, and/or cardiac magnetic resonance imaging.
Targeted next-generation and direct sequencing were used for candidate gene analysis and mutation scanning. Ion
channels were expressed in HEK293 cells and studied using patch-clamp recordings.
RESULTS SND and biventricular NCCM were diagnosed in multiple members of a German family. Segregation analysis
suggested autosomal-dominant inheritance of the combined phenotype. When looking for potentially disease-causing
gene variants with cosegregation, a novel hyperpolarization-activated cyclic nucleotide channel 4 (HCN4)-G482R
mutation and a common cysteine and glycine-rich protein 3 (CSRP3)-W4R variant were identiﬁed. HCN4-G482R is located
in the highly conserved channel pore domain. Mutant subunits were nonfunctional and exerted dominant-negative
effects on wild-type current. CSRP3-W4R has previously been linked to dilated and hypertrophic cardiomyopathy,
but was also found in healthy subjects. Moreover, different truncation (695X) and missense (P883R) HCN4 mutations
segregated with a similar combined phenotype in an additional, unrelated family and a single unrelated proband
respectively, which both lacked CSRP3-W4R.
CONCLUSIONS The symptom complex of SND and NCCM is associated with heritable HCN4 defects. The NCCM
phenotype may be aggravated by a common CSRP3 variant in one of the families. (J Am Coll Cardiol 2014;64:757–67)
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ABBR EV I A T I ON S
AND ACRONYMS
CMR = cardiac magnetic
resonance imaging
CS = cover slips
CSRP3 = cysteine and glycine-
rich protein 3
HCN = hyperpolarization-
activated cyclic nucleotide
channel
LVEF = left ventricular ejection
fraction
MVP = mitral valve prolapse
NCCM = noncompaction
cardiomyopathy
NGS = next-generation
sequencing
SAN = sinoatrial node
SND = sinus node dysfunct
Schweizer et al. J A C C V O L . 6 4 , N O . 8 , 2 0 1 4
HCN4 Mutations Linked to SND and NCCM A U G U S T 2 6 , 2 0 1 4 : 7 5 7 – 6 7
758N oncompaction cardiomyopathy(NCCM) is characterized by excessiveventricular hypertrabeculation and
complicated by heart failure, arrhythmia, and
thromboembolic events (1). Mutations in genes
encoding sarcomeric, cytoskeletal, Z-disk, chap-
erone, Notch-pathway, or nuclear membrane
proteins have been related to the disorder (2–5).
However, a comprehensive analysis of the ge-
netic basis of NCCM is not available to date,
and genotype-phenotype correlations are poorly
understood (2).SEE PAGE 768Sinus node dysfunction (SND) is associated
with syncope or bradyarrhythmic death and
frequently requires cardiac pacemaker im-
plantation. The hyperpolarization-activatedcyclic nucleotide channel 4 (HCN4) is a major constit-
uent of the pacemaker current (If) in the sinoatrial
node (SAN) and contributes signiﬁcantly to sponta-
neous diastolic depolarization (6–8). Accordingly,
mutations in the HCN4 gene were associated with fa-
milial forms of SND (9–12). Abnormalities of SAN
function are particularly common in heart failure,
suggesting a genetic and mechanistic link between
electrical and structural dysfunction (13). Indeed, the
depolarizing cardiac sodium channel gene SCN5A and
non–ion channel genes MYH6 and CASQ2 have
recently been implicated in the pathogenesis of both
SND and structural heart disease (14–16). However,
genetic overlap between SND and NCCM has not been
previously described.
In this paper, we report on a symptom complex
comprising SND and NCCM observed in 2 unrelated
families and in an additional unrelated proband. In a
candidate gene approach, we identiﬁed a novel
HCN4-G482R loss-of-function mutation that segre-
gated with all affected members in the index family.
In addition, a common cysteine and glycine-rich
protein 3 (CSRP3)-W4R variant that has previously
been found in dilated and hypertrophic cardiomyop-
athy patients and in healthy subjects (17–19) coseg-
regated with the clinical syndrome in the family.
Furthermore, multiple members of a previously re-
ported family (11) and an unrelated proband exhibited
similar combined phenotypes and carried truncation
(695X) (11) and missense (P883R) HCN4 mutations,
respectively, but lacked CSRP3-W4R.
Our results conﬁrm a primary role of HCN4 chan-
nels in cardiac pacemaker function and in SND.
Furthermore, the data give rise to the notion that
HCN4 channels are implicated in the formation of
ionventricular structure and may contribute to the
development of NCCM when dysfunctional.
METHODS
A detailed description of the methods is provided in
the Online Appendix.
PATIENTS AND CLINICAL INVESTIGATIONS. Patients
were evaluated by clinical examination, 12-lead
electrocardiogram (ECG), 24-h Holter recording, ex-
ercise test, echocardiography, and cardiac magnetic
resonance imaging (CMR). Holter recordings were
pre-analyzed using H-Scribe 4.0 software (Mortara,
Essen, Germany) and validated by an electrophysiol-
ogist. All patients provided written informed consent
prior to clinical and genetic investigations. The Ethics
Committee of Heidelberg University (Germany)
approved the research protocol, and the investigation
conforms to the principles outlined in the Declaration
of Helsinki.
CANDIDATE GENE ANALYSIS AND VALIDATION IN
THE INDEX FAMILY. Targeted next-generation sequ-
encing (NGS) and direct sequencing were employed in
the index family to analyze genes commonly involved
in cardiomyopathies and heart rhythm disorders
(Online Table 1). NGS was performed on an Illumina
HiSeq2000 (Illumina, San Diego, California) using the
paired end 2x100bp method (Online Appendix). Var-
iations present in the publicly available variant
database “dbSNP137common” and ﬂagged as vali-
dated by frequency, indicating an allele frequency
of $1% in populations, were considered to have a
benign effect and therefore were excluded from
further analysis. Other genetic variants were retained
and tested for segregation in the family by Sanger
sequencing.
COMPREHENSIVE MUTATION SCANS IN A SINUS
BRADYCARDIA COHORT. We carried out compre-
hensive mutation scans of HCN4 using direct exon
sequencing in a cohort of 86 unrelated patients diag-
nosed with sinus bradycardia. Study subjects were
included in the cohort when resting heart rates and
minimum heart rates were <60 and <40 beats/min,
respectively. Probands with prolonged QT intervals or
ischemic heart disease were excluded. Sequencing of
the exon harboring the HCN4 mutation was then per-
formed in relatives of each proband to determine their
mutation carrier status. Probands and their families
diagnosed with a combined phenotype of sinus
bradycardia and myocardial noncompaction also were
tested for carrying CSRP3-W4R by direct sequencing.
MUTAGENESIS. Site-directed mutagenesis (QuikChange
II Site-Directed Mutagenesis Kit, Stratagene, La Jolla,
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FIGURE 1 Pedigrees of Families Affected by SND and NCCM Associated With
HCN4 Mutations
(A) Index family A carrying the novel HCN4-G482R mutation. (B) Family B with members
heterozygously affected by the HCN4-695X mutation (11). (C) Pedigree of the single
proband heterozygous for HCN4-P883R. Closed symbols indicate affected family
members, open symbols denote unaffected family members, and gray symbols indicate
unknown phenotype. Left half of symbol indicates status concerning sinus bradycardia,
and right half of symbol reﬂects myocardial noncompaction status. The index patient is
denoted by an arrow. Circles refer to women, and squares indicate men. Individuals that
received an electronic cardiac pacemaker aremarked by PM, and SD indicates individuals that
experienced sudden death. Slashed symbols indicate deceased subjects with an unknown
genotype and phenotypic characterization based on medical records and family history.
Red signs indicate respective HCN4mutation status, and slate signs reﬂect
CSRP3-W4R genotype (plus symbol indicates carrier of mutant allele, minus symbol
denotes wild-type allele). HCN ¼ hyperpolarization-activated cyclic nucleotide channel;
CSRP = cysteine and glycine-rich protein; NCCM ¼ noncompaction cardiomyopathy;
SND ¼ sinus node dysfunction.
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759California) was performed to introduce the G482R
mutation into the human HCN4 gene (GenBank
accession number NM_005477). Automated DNA
sequence analysis (GATC Biotech, Konstanz, Ger-
many) veriﬁed the mutation.
CELL CULTURE. Human embryonic kidney cells
(HEK293) were grown on glass cover slips (CS) (3  104
cells per CS) in Dulbecco’s Modiﬁed Eagles’s Medium
supplemented with 2 mM glutamine, 10% fetal calf
serum, 100 U/ml penicillin-G sodium, and 100 mg/ml
streptomycin sulfate in 5% CO2 at 37C. Cells were
transfected using the calcium-phosphate method
with 0.6 mg plasmid DNA per CS encoding mutant or
wild-type HCN4 channel subunits. Successful trans-
fection was visualized by coexpressed CD8 antigen
(0.1 mg DNA/CS) identiﬁed by anti-CD8 antibody-
coated dynabeads (Life Technologies, Carlsbad, Cali-
fornia). In coexpression experiments, equal amounts
(0.3 mg) of mutant and wild-type DNA were used (11).
CELLULAR ELECTROPHYSIOLOGY. Membrane cur-
rents were recorded 1 to 2 days after transfection
under voltage-clamp conditions (whole-cell conﬁgu-
ration) at room temperature (21C to 23C) as pub-
lished (11). Functional properties of HCN4 channels
were investigated employing different voltage pro-
tocols as reported (11,20).
STATISTICS AND DATA ANALYSIS. Electrophysio-
logical data were recorded and analyzed ofﬂine using
Signal software (Version 4.05; CED, Cambridge,
England). GraphPad Instat (Version 3.06; La Jolla,
California) was used for statistical analyses. All
results are provided as mean  SEM. Data were tested
for normality (Kolmogorov-Smirnov test), and a
2-tailed unpaired Student t test, followed by a Welch
correction to account for unequal variances was used
for statistical comparisons. A Mann-Whitney test was
performed for comparison of current densities (mo-
lecular electrophysiology) that did not follow
Gaussian distributions. A p value <0.05 was consid-
ered statistically signiﬁcant.
RESULTS
CLINICAL CHARACTERISTICS OF INDEX FAMILY.
The 23-year-old index patient of family A (IV.1)
(Fig. 1A) presented with syncope resulting in a car
accident. He complained dizziness, fatigue, palpita-
tions, and was aware of bradycardia since childhood.
Resting 12-lead electrocardiogram showed sinus
bradycardia, ﬁrst-degree atrioventricular block, and
T-wave inversions in the inferior leads (Fig. 2A). The
QTc interval was normal (Table 1). Holter recordingdemonstrated minimum and average heart rates of 21
and 34 beats/min, respectively (Figs. 2B and 2C,
Table 1). Exercise testing revealed impaired chrono-
tropic capacity, intermittent ectopic atrial rhythms,
and ventricular bigeminy (Figs. 2D and 2E). In ad-
dition to the electrical phenotype, transthoracic
echocardiography exhibited biventricular hyper-
trabeculation that met diagnostic criteria of left ven-
tricular noncompaction, according to Jenni or Chin
(21), and mitral valve prolapse (MVP) (Figs. 3A and
3D, Online Video 1). Pronounced intracavitary trabe-
culations and perfused intertrabecular recesses were
apparent in right and left ventricular walls (Figs. 3A
and 3D, Online Videos 1 and 2), and basal left ven-
tricular longitudinal strain was attenuated (Online
Table 2). CMR conﬁrmed that noncompacted seg-
ments mainly involved apical, lateral, and inferior
walls of the left ventricle (Figs. 4A and 4B). Left ven-
tricular ejection fraction (LVEF) was preserved
despite signiﬁcant noncompaction (Table 1). The pa-
tient received a dual chamber pacemaker. During
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FIGURE 2 Electrophysiological Characteristics of Index Family Members
(A) Standard 12-lead electrocardiography of the index patient (VI.1) demonstrating sinus bradycardia. (B) Heart rate proﬁle of VI.1 monitored by 24-h Holter recording
shows hourly values for average, maximum, and minimum heart rate, respectively. (C) Minimum heart rate (21 beats/min) recorded at night. (D, E) During exercise, the
patient exhibited ectopic atrial rhythms (D) and ventricular bigeminy (E). The arrow indicates altered P-wave polarity. (F) Atrial rate histograms obtained during
pacemaker follow-up 6 months after implantation. (G) Sinus node recovery time determined via the implanted pacemaker. (H, I) Illustration of heart rate variability
during day (left panels) and night (right panels) Holter recording. (H) Poincaré plots of patient VI.2 display comet-shaped patterns reﬂecting increased beat-to-beat
dispersion. At night, NN intervals markedly exceeded 2,000 ms. (I) Plots of a healthy individual for comparison (modiﬁed from Schweizer et al. [11]). NN = interval
between successive heart beats in the Holter recording.
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7606-month follow-up he did not report any recurrence
of symptoms. Pacemaker interrogation revealed that
atrial rates were below 60 beats/min during 96.8% of
the follow up period, and sinus node recovery time
was prolonged (1,900 ms; corrected sinus node re-
covery time, 650 ms) (Figs. 2F and 2G).
Family analysis (Fig. 1A) identiﬁed the patient’s
sister (IV.2; 16 years of age) (Figs. 2H and 2I, Figs. 3B
and 3E, Online Videos 3 and 4, Fig. 4C, Table 1,
Online Table 2) and mother (III.2; 45 years of age)
(Figs. 3C and 3F, Online Videos 5 and 6, Table 1, Online
Table 2), as affected by the symptom complex
comprising SND, NCCM, and MVP. Of note, no
extracardiac anomalies were apparent, and none of
the patients actively practiced or had a history ofendurance sports that might explain a vagotone-
mediated sinus bradycardia. Advanced functional
echocardiographic analyses revealed impaired apical
rotation (22) in all affected family members (Online
Fig. 1). Patient III.2 showed impaired LVEF and
symptomatic heart failure (New York Heart Associa-
tion functional class II to III), while patient IV.2
exhibited preserved LVEF similar to the index patient
(Table 1). No overlap with other cardiomyopathies
was observed. Clinically affected patients did not
receive any medication at the time of evaluation. The
father (III.3) of the index patient exhibited impaired
LVEF due to myocardial infarction 5 years prior and
was treated according to current guidelines. Clinical
evaluation showed normal sinus node function and
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761no signs of myocardial noncompaction (Table 1,
Online Table 2, Fig. 3, Online Video 7). Furthermore,
the grandmother (II.2), granduncle (II.3), and great-
grandfather (I.1) on the maternal side of the index
patient had a history of sinus bradycardia and
congestive heart failure, and they had received
pacemakers implanted between 40 to 50 years of age.
Patients I.1 and II.2 died from stroke at 73 and 54
years of age, respectively, while patient II.3 experi-
enced sudden death at 50 years of age. As these
probands had passed away at the time of family
assessment, they were not available for further
clinical or genetic analysis.
GENETIC ANALYSIS IN THE INDEX FAMILY.
Candidate analysis of genes commonly involved in
cardiomyopathies and cardiac arrhythmias (Online
Table 1) was carried out in the index family using
targeted next-generation and direct Sanger se-
quencing. We found 593 variants in the index patient
(Fig. 1A). No truncating variant was identiﬁed.
Filtering out noncoding, synonymous, and benign
variants present in the dbSNP137 common database
yielded 9 nonsynonymous variants that were vali-
dated and tested in the family for segregation by
Sanger sequencing. Disease relevant segregation
compatible with an autosomal recessive trait was not
observed (e.g., no variant was homozygously shared
by the affected individuals). However, pedigree
analysis (Fig. 1A) suggested autosomal dominant in-
heritance. Six heterozygous variants were detected
in the index patient and shared by other family
members (Online Table 3). Of those, 2 variants (HCN4-
G482R and CSRP3-W4R) were detected in each family
member showing the combined phenotype (III.2, VI.1,
and VI.2) but not in the nonaffected father (III.3)
(Fig. 1A). The novel HCN4 variant was heterozygously
carried by all affected family members and absent
from 566 unrelated controls. It results in replacement
of a glycine residue with arginine and is located in the
highly conserved Glycine-Tyrosine-Glycine motif of
the channel pore (G482R) (Figs. 5A to 5D). Further-
more, patient III.2 was homozygous for the common
CSRP3-W4R variant (19), while her son (VI.1) and
daughter (VI.2) were heterozygous.
PREVALENCE OF MYOCARDIAL NONCOMPACTION
IN A SINUS BRADYCARDIA COHORT. We investigated
a cohort of 86 unrelated probands with sinus brady-
cardia by comprehensive echocardiography and/or
CMR and discovered 3 individuals that exhibited
myocardial noncompaction. Interestingly, we found
mutations in the exon sequence of HCN4 in all
3 probands affected by the combined phenotype
within this cohort. In addition to the index patient of
A
IV.1 IV.2 III.2
B C
D E F
FIGURE 3 Echocardiographic Characteristics
Transthoracic apical end-diastolic views (top) and perfusion indicated by color-coded duplex imaging (bottom) of family A: patients IV.1
(A, D, Online Videos 1 and 2), IV.2 (B, E, Online Videos 3 and 4), and III.2 (C, F, Online Videos 5 and 6) illustrate myocardial noncompaction. For
comparison please refer to the transthoracic echocardiography cine sequences of nonaffected family member III.3 (Online Video 7).
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762family A, who was heterozygous for HCN4-G482R and
CSRP4-W4R (Fig. 1A), a patient and multiple members
of his family carried the previously reported HCN4-
695X mutation (11) (Fig. 1B, Online Fig. 2). Further-
more, in another unrelated patient, we detected a
heterozygous HCN4-P883R mutation (Fig. 1C, Online
Fig. 3) that was absent from 566 unrelated controls.
However, the CSRP3-W4R variant was not present
in any of these 2 latter probands and their families,
respectively.
PATIENTS CARRYING HCN4-695X AND HCN4-P883R
EXHIBIT COMBINED PHENOTYPES. We observed
biventricular hypertrabeculation in multiple mem-
bers of the previously reported family affected by theFIGURE 4 Biventricular Noncompaction Visualized by Cardiac Magn
Representative end-diastolic 2-chamber (A) and short-axis views (B) of
IV.2, family A. Arrows indicate areas of prominent intracavitary trabeculHCN4-695X mutation (11) (Fig. 1B, Online Fig. 2).
Although LVEF was preserved and no overt structural
abnormalities were initially noted (11), all family
members carrying HCN4-695X that were examined by
multi-modal imaging exhibited biventricular hyper-
trabeculation (Online Fig. 2) and MVP. The patient
that heterozygously carried the HCN4-P883R muta-
tion (Fig. 1C, Online Fig. 3) presented with sinus
bradycardia (35 to 40 beats/min) and paroxysmal
atrial ﬁbrillation (bradycardia-tachycardia syndrome)
and required pacemaker implantation. Echocardiog-
raphy/CMR revealed myocardial noncompaction with
preserved LVEF resembling the combined phenotype
of the aforementioned HCN4 mutation carriers.etic Resonance Imaging
the index patient (family A, VI.1). (C) Four-chamber view of proband
ations. LV ¼ left ventricle; RV ¼ right ventricle.
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FIGURE 5 Sequence Identiﬁcation of the HCN4 Mutation in the Index Family
(A, B) DNA sequence analysis of cloned wild-type (WT) and mutant DNA revealed a transition of nucleotide G1444 to A. (C) Conservation of
residue G482 is demonstrated by amino acid sequence alignments of the HCN4 channel pore region for human, bovine, mouse, rat, zebraﬁsh,
chicken, and Tasmanian devil orthologs, and for human hyperpolarization-activated cyclic nucleotide (HCN) channels 1, 2, and 3. (D)
Predicted HCN4 subunit topology. The mutation within the Glycine-Tyrosine-Glycine (GYG) motif of the channel pore is indicated by the
asterisk. S ¼ transmembrane segment.
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763CELLULAR PHENOTYPE OF HCN4-G482R CHANNEL
SUBUNITS. Functional effects associated with the
HCN4-G482R mutation were studied in HEK293 cells
expressing HCN4 channels using the whole-cell patch
clamp technique (Fig. 6A). Mutant HCN4-G482R sub-
units did not produce relevant hyperpolarization-
activated inward currents, reﬂecting loss-of-function
(Fig. 6A). To mimic the heteromeric conﬁguration
present in affected patients, cells were cotransfected
with equal amounts of plasmid DNA encoding for
wild-type and mutant HCN4 subunits. I-V relation-
ships showed lower current densities of heteromeric
compared to wild-type channels (Fig. 6B). Quantiﬁ-
cation during single voltage pulses to –120 mV (4 s)
yielded wild-type HCN4-mediated current densities
of –110.8  15.8 pA/pF (n ¼ 10) compared to –38.4 
8.8 pA/pF (n ¼ 32) in the heteromeric conﬁguration
(p < 0.01) (Fig. 6C, Online Table 4). Activation and
deactivation properties and reversal potential of
HCN4 wild-type currents were not signiﬁcantly
affected by coexpression of G482R (Figs. 6D to 6F,
Online Table 4). To investigate whether altered
membrane trafﬁcking could underlie current reduc-
tion, we analyzed HEK cells that expressed wild-type
and mutant channels in heteromeric and homomeric
conﬁguration, using mutant constructs FLAG-tagged
at the N-terminal region. Confocal microscopyshowed similar surface expression of HCN4 wild-type
and mutant subunits indicating equivalent trafﬁcking
(Online Fig. 4). Overlapping immunoreactivity sug-
gested equal distribution and colocalization of
wild-type and mutant FLAG-HCN4-G482R subunits.
DISCUSSION
We describe a previously unrecognized electrome-
chanical overlap syndrome of SND and NCCM with
autosomal-dominant inheritance in 2 German fam-
ilies and a single proband. Our approach highlights
the use of NGS to uncover the underlying genetic
basis of combined cardiovascular disorders. A novel
HCN4-G482R mutation and a common CSRP3-W4R
variant (19) were identiﬁed and found to cosegregate
in the index family. Moreover, the previously re-
ported HCN4-695X mutation cosegregated in the
second family (11) and a HCN4-P883R mutation was
identiﬁed in a single proband—both were clinically
characterized by the combined phenotype. While
HCN4 dysfunction represents an established mecha-
nism of SND (9–12), we for the ﬁrst time have linked
mutations in HCN4 to a structural cardiac defect.
MOLECULAR ELECTROPHYSIOLOGY UNDERLYING
HCN4-G482R ASSOCIATED SND. The replacement of
glycine by arginine (G482R) within the highly
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FIGURE 6 Functional Characterization of HCN4-G482R Subunits
(A) Representative current traces recorded from HEK293 cells expressing wild-type (WT),
heteromeric WT-G482R, or homomeric G482R subunits using the indicated voltage pro-
tocol. (B) I-V relationships show hyperpolarization-activated cyclic nucleotide channel 4
(HCN4) current reduction in the presence of G482R subunits compared to WT channels. (C)
Current densities determined at –120 mV membrane potential. (D) Activation curves of WT
and heteromeric WT-G482R channels, obtained using the voltage protocol described in A.
(E) Deactivation properties were examined using the indicated paired pulse protocol.
Representative current traces (left) and resulting deactivation curves (right) are depicted.
(F) Reversal potential recordings. Voltage protocol (left, top), representative current
traces (left, bottom), and resulting mean values (right) are shown for indicated subunits.
Data are provided as mean  SEM. **p < 0.01.
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and 5D) suggests a major impact on ion permeation.
Accordingly, patch-clamp recordings revealed that
homozygous HCN4-G482R channels were nonfunc-
tional (Figs. 6A and 6C). Heteromeric channels
composed of mutant and wild-type HCN4 subunits
exhibited w65% current reduction compared to wild-
type channels (Fig. 6C), indicating a dominant-
negative effect as primary mechanism of If currentreduction in heterozygous patients. At the molecular
level, current decrease may be caused by altered
functional properties of the channel and/or by
impaired cell surface expression. HCN4-G482R sub-
units did not affect surface expression of the channels
(Online Fig. 4). In addition, there were no changes in
activation or deactivation parameters (Figs. 6D and
6E), conﬁrming defective ion permeation as under-
lying mechanism.
Carriers of HCN4-G482R exhibited sinus brady-
cardia in agreement with previous reports on HCN4
dysfunction (9,11). While slow heart rates associated
with HCN4 mutations reported were mostly asymp-
tomatic and benign, HCN4-G482R carriers were
severely affected and showed pronounced rate
decrease leading to syncope and requiring pacemaker
implantation in the index patient. The particularly
severe bradycardia phenotype may be explained by
dominant-negative reduction of If current induced by
mutant HCN4-G482R subunits in the SAN.
THE MECHANISTIC SIGNIFICANCE OF HCN4
DYSFUNCTION IN NCCM. In addition to its estab-
lished function in cardiac pacemaking, HCN4 was
recently identiﬁed as a primary marker for cardiac
progenitors of the ﬁrst heart ﬁeld, signiﬁcantly
involved in the early embryonic heart development,
forming main parts of the cardiac muscle, and the
conduction system (23,24). During later development,
HCN4 is down-regulated in the working myocardium,
and abundant expression is restricted to the SAN and
the conduction system (7). Based on these ﬁndings,
we hypothesize that functional HCN4 loss interferes
with molecular mechanisms required during cardiac
development, resulting in NCCM (Central Illustration).
Myocardial compaction occurs at 5 to 8 weeks of
gestation, and impairment or arrest of this process
gives rise to hypertrabeculation (25). In this regard,
recent data suggested that Notch-pathway distur-
bance causes noncompaction with congenital heart
disease while sarcomere, cytoskeletal, and Z-disk
mutations provoke a more myocardial disease-only
phenotype (26). In support of a congenital origin
both juvenile HCN4-G482R mutant-carriers (patients
IV.1 and IV.2) exhibited marked hypertrabeculation
and additional MVP early in life. Hence, a potential
implication of HCN4 in signaling pathways involved
in ventricular wall maturation and compaction (e.g.,
Notch, Neuregulin, Ephrin, or Bone morphogenic
protein) (26) is of particular interest and requires
future investigation.
Based on the clinical observations among our
study patients, it appears surprising that no struc-
tural cardiac abnormalities were reported on HCN4
knockout mice (27). This ﬁnding may be explained
CENTRAL ILLUSTRATION Proposed Pathogenetic Process
At early embryonic stages, HCN4 is highly expressed in the immature human ventricle (A),
followed by down-regulation after day 30 (Carnegie stage 12) (30). At postnatal stages,
signiﬁcant HCN4 activity is restricted to the sinoatrial node (SAN) and the conduction
system (B), crucial for cardiac automaticity. We hypothesize that regular HCN4 function
and expression patterning throughout early embryonic development are pre-requisites for
normal ventricular wall maturation, involved in processes that regulate myocardial
compaction and proper mitral valve formation (A, B). HCN4 loss-of-function (C) may
interfere with these mechanisms and hence in addition to sinus node dysfunction give rise
to noncompaction and mitral valve defects (D). Spatial and temporal HCN4 activity is
illustrated by color. AVN ¼ atrioventricular node; C ¼ conus arteriosus; LA ¼ left atrium;
LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle; T ¼ truncus arteriosus;
VCS ¼ ventricular conduction system.
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765by death of homozygous animals at early embryonic
stages, most likely due to failure of rate initiation
(27). Heterozygous animals, however, were reported
indistinguishable from wild-type littermates, while
detailed post-natal structural investigations have
not been performed (27). Furthermore, an absence
of noncompaction phenotypes in mouse models is a
previously described phenomenon (22). Luedde
et al. (22) reported an NCCM-related human
troponin T mutation that lacked an obvious non-
compaction phenotype in their transgenic mouse
model. It was speculated whether differences in
species might render mice more resistant to NCCM
phenotype (22). Consistent with this notion, data
from other genetic cardiomyopathy models in ro-
dents observed speciﬁc phenotypes only in certain
strains (28), indicating the importance of a human-
speciﬁc or at least distinctive predisposing genetic
background.
POTENTIAL ROLE OF CSRP3-W4R IN THE INDEX
FAMILY. Hetero- (patients VI.1 and VI.2) or homo-
zygous (patient III.2) cosegregation of CSRP3-W4R
with the clinical phenotype in the index family
suggests that this variant also may contribute to the
structural phenotype. However, CSRP3-W4R was
reported prevalent in up to 1% of control probands
(19,29) and has never been linked to NCCM despite
its high allele frequency. Functional characteriza-
tion of CSRP3-W4R using a knock-in mouse model
(29) revealed that it contributes to hypertrophic
cardiomyopathy and heart failure in mice. In
humans, it was previously detected in dilated car-
diomyopathy and hypertrophic cardiomyopathy pa-
tients but often failed to clearly segregate with
either disease in families (17). Hence, it was sug-
gested that CSRP3-W4R does not represent a
disease-causing mutation in humans, but serves as
phenotypic modiﬁer in cardiomyopathies (18). It is
reasonable to speculate in this context that the
disposition to HCM associated with CSRP-W4R
could aggravate the NCCM phenotype on the basis
of an underlying HCN4-G482R mutation. Support-
ing this notion, patient III.2, who exhibited the
most severe NCCM phenotype, is homozygous for
CSRP3-W4R.
VENTRICULAR HYPERTRABECULATION IN SND
PATIENTS. Whether HCN4-G482R alone or together
with CSRP3-W4R underlies patients’ hypertrabe-
culation cannot be clariﬁed within the index family,
as all affected members alive carry both mutations
(Fig. 1A). To address this issue, we carried out
multimodal imaging and performed mutation scans
of HCN4 in a cohort of 86 unrelated patientsdiagnosed for sinus bradycardia. We identiﬁed
2 additional unrelated patients that carried HCN4
mutations and exhibited the combined phenotype:
The index patient of the previously reported HCN4-
695X mutation family (11) and a single proband that
carried a heterozygous HCN4-P883R mutation. Of
note, CSRP3-W4R was not present in these patients.
Based on these ﬁndings, we re-evaluated the cardiac
morphology of family members, carrying the HCN4-
695X mutation and of their unaffected relatives (11)
(Fig. 1B, Online Fig. 2). Although LVEF was pre-
served and no overt structural abnormalities were
initially noted (11), all HCN4-695X mutant-carriers
examined by comprehensive echocardiography and/
or CMR exhibited biventricular hypertrabeculation
(Online Fig. 2). These changes were less severe than
in patients carrying HCN4-G482R, which might be
explained by the fact that 695X compromises cAMP
responsiveness of the HCN4 channel but not ion
permeation itself and/or by the absence of CSRP3-
W4R in carriers of the HCN4-695X mutation.
Furthermore, the proband heterozygously carrying
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Mutations in the HCN4 gene are linked to a symptom
complex of SND and myocardial noncompaction.
TRANSLATIONAL OUTLOOK: Future studies are
required to determine the clinical utility of genetic
testing and long-term cardiac rhythm monitoring in
patients with myocardial noncompaction.
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and was affected by SND requiring pacemaker im-
plantation (Online Fig. 3). This case provides addi-
tional, independent evidence that validates the
association of the proposed disease entity with mu-
tations in HCN4. Based on these data, it appears
unlikely that CSRP3-W4R present only in the index
family serves as primary cause of the NCCM pheno-
type. Thus, our study strongly supports the notion
that HCN4 mutations are critically involved in the
development of myocardial noncompaction.
STUDY LIMITATIONS. In this study, we did not carry
out experiments on the pathogenetic role of HCN4
during heart development and the modifying contri-
bution of the CSRP3 variant. Such studies will be
necessary to elucidate the mechanistic implication of
HCN4 defects in ventricular malformation and to
validate its signiﬁcance for NCCM.
CONCLUSIONS
We report for the ﬁrst time that HCN4 channel
dysfunction in addition to its known association
with SND may play a distinct role in the develop-
ment of structural cardiac abnormalities. The novel
HCN4 loss-of-function mutation G482R was identi-
ﬁed and segregated with a combined disease
phenotype in family members with SND and NCCM.The structural phenotype might be modiﬁed by the
common CSRP3-W4R variant in the index family.
Different HCN4 mutations (695X and P883R) segre-
gated with a similar combined phenotype in an un-
related family and in a single unrelated proband and
further support a disease-relevant association with
HCN4.
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